BALPHARMANSEBal Pharma Limited· PharmaceuticalsMinimalNeutral
Announced Mon, 16 Jun · 16:57 IST

Bal Pharma Limited has informed the Exchange regarding 'Intimation to physical shareholders to update KYC.

BALPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Bal Pharma Limited has informed the stock exchanges that it is sending reminders to shareholders who still hold shares in physical (paper) form, asking them to update their KYC details with the company's Registrar and Transfer Agent, MUFG Intime India Private Limited. This is being done as required by recent SEBI circulars (dated May 7, 2024 and June 10, 2024) which make it mandatory for all physical security holders to provide PAN, address with PIN code, mobile number, bank account details, specimen signature, and optionally email ID and nomination. Shareholders who do not update these details will only receive dividends or interest through electronic mode from April 1, 2024 onwards. The company has provided the relevant KYC forms (ISR-1, ISR-2, and SH-13) along with the letter and has made them available on its website (www.balpharma.com) and the RTA's website. Shareholders can submit the forms in person, by hard copy, or through e-sign/e-mail as per the instructions provided.

Likely market impact

This is a routine regulatory compliance filing and does not have any direct material impact on the company's financials or stock price. Shareholders holding physical shares should update their KYC details to avoid any disruption in receiving future dividend payments.